Last News
 |
| Credit: Michael M. Santiago/Getty Images) |
As soon as this week, Apple intends to suspend the sale of some Watch models in the US in order to pursue what may turn out to be one of the most significant patent conflicts in recent memory.
The Apple Watch Series 9 and Apple Watch Ultra 2 will no longer be sold, the company confirmed to CNN. This will happen on Thursday on Apple.com and in-store after December 24.
Due to an ongoing disagreement with medical device manufacturer Masimo regarding the product's blood oxygen function, the company decided to remove one of its most well-known items from the market. Since Apple has consistently promoted its smartwatch as a life-saving tool, it has become the most widely-sold watch globally. However, her altercation with "Massimo" puts everything in jeopardy.
The US International Trade Commission declared in October that Apple had violated a patent owned by Masimo, the maker of the pulse oximeter that measures blood oxygen levels using light. Before the prohibition takes effect, President Biden has sixty days to reconsider the decision.
"Although the review period will not end until December 25, Apple is taking proactive steps to comply if the ruling stands," the company stated in a statement.
She went on to say, "Apple is pursuing a number of legal and technical options to ensure the watch is available to customers and strongly disagrees with the matter."
According to the business, "all measures will be taken to return Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the United States as soon as possible" if the injunction is kept in place.
September marked the release of Apple's Series 9 phone. A better neural engine that interprets data from sensors and machine learning is one of the reasons it has a unique S9 chip for speedier processing and allows hand gestures to operate the watch.
ongoing dispute
Apple declared that it is certain the ITC's conclusions are false and need to be overturned. Additionally, it intends to appeal the ruling to the Federal Circuit.
Apple further claimed to have provided information demonstrating the ban's detrimental effects on scientific and medical research, healthcare, and Watch users who depend on features like blood oxygen, ECG, and other health-related data.
The CEO of Masimo, Joe Kiani, told CNN that he thinks the move to halt sales of the devices is the most recent development in the continuing legal dispute over patents.
"This was a purposeful infraction," Kayani declared, characterizing the sales stoppage as a means of exerting pressure on Biden.
Apple made no effort to reach a settlement with Masimo. However, Kayani stated he was amenable to it.
effect on sales
According to David McQueen, head of ABI Research, the move to keep watches on sale until December 24 will lessen the financial impact of the pause hit and give consumers more time to purchase gadgets before Christmas.
Even while Apple leads this industry with a about 24% market share, he continued, "if it manages to boost sales in these last few days, it may not actually impact its business much, assuming there is available stock." "It might be able to make it through the holiday season without substantially hurting sales," he went on.
In 2022, Apple sold 49 million smart watches, and in the first nine months of 2023, it sold roughly 26.7 million.
"It will be interesting to see how long the dispute lasts, when Apple opens its wallet, and when the ban is lifted," the speaker continued.
